$0.44
−3.83%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$0.44
From 52W high−79.98%
Volume154781.00
Market cap$11.07M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataNov 4, 2026
Open
$0.44
From 52W high
−79.98%
Volume
154781.00
Market cap
$11.07M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.2x
P/E (TTM)
—
RSI (14)
29.5
MomentumView details →
1D Return
−3.83%
YTD Return
−54.88%
SummaryUpdated Jun 1, 2026
Hoth Therapeutics, Inc. (NASDAQ:HOTH) is a clinical-stage biopharmaceutical company founded in 2017 and headquartered in New York, New York. The company went public in February 2019 and focuses on developing innovative therapies for unmet medical needs across multiple therapeutic areas. Named after the ice planet from Star Wars, Hoth operates as a development-stage biotechnology company with no current revenue, dedicating its resources to advancing a diverse pipeline of drug candidates through clinical trials and regulatory processes.
Similar companies
Latest newsMore news →